gip/glp-1 receptor agonist mechanism of action of GLP-1 [25] GLP-1: Actions on Beta-cell Mass

Recent advancementsincluding the approval of oral semaglutide (Rybelsus)have demonstrated the potential for effective oral peptide delivery, though such formulations still face significant pharmacokinetic and formulation-related challenges

Scientists were chasing an incretin hormone, and when GLP-1 was finally discovered, we found that it had a pronounced satiety effect, slowed down gastric emptying, and actually reduced postprandial insulin response

The approval could expand access to an effective therapy for managing obesity.

RegenMD prescribes compounded GLP-1 therapy with personalized dosing tailored to your body and goals

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users